188 related articles for article (PubMed ID: 29535328)
21. Establishment of a P-glycoprotein substrate screening model and its preliminary application.
Wang Y; Cao J; Zeng S
World J Gastroenterol; 2004 May; 10(9):1365-8. PubMed ID: 15112361
[TBL] [Abstract][Full Text] [Related]
22. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.
Haritova A; Urumova V; Lutckanov M; Petrov V; Lashev L
Food Chem Toxicol; 2011 Jul; 49(7):1530-6. PubMed ID: 21458518
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of dietary polyphenols on oral pharmacokinetics of cyclin-dependent kinase inhibitors in rats: a mechanistic framework for in vitro-in vivo extrapolation.
Patil PH; Desai MP; Birangal S; Gautham Shenoy G; Channabasavaiah JP
J Pharm Pharmacol; 2024 Jan; 76(2):93-105. PubMed ID: 38085101
[TBL] [Abstract][Full Text] [Related]
25. The effects of cyclosporine A or activated charcoal co-administration on the pharmacokinetics of enrofloxacin in chickens.
Petkova T; Milanova A; Poźniak B
Poult Sci; 2023 Jan; 102(1):102225. PubMed ID: 36343435
[TBL] [Abstract][Full Text] [Related]
26. Natural P-gp inhibitor EGCG improves the acteoside absorption in Caco-2 cell monolayers and increases the oral bioavailability of acteoside in rats.
Zhou F; Huang W; Xu T; Wu L; Chen Q; Peng J; Liu X; Lu B
Food Chem Toxicol; 2020 Dec; 146():111827. PubMed ID: 33184029
[TBL] [Abstract][Full Text] [Related]
27. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
Pingili RB; Pawar AK; Challa SR
Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
[TBL] [Abstract][Full Text] [Related]
28. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
Singh S; Kushwah V; Agrawal AK; Jain S
Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein expression in the gastrointestinal tract of male and female rats is influenced differently by food.
Dou L; Mai Y; Madla CM; Orlu M; Basit AW
Eur J Pharm Sci; 2018 Oct; 123():569-575. PubMed ID: 30118850
[TBL] [Abstract][Full Text] [Related]
30. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
[TBL] [Abstract][Full Text] [Related]
31. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
32. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
33. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
[TBL] [Abstract][Full Text] [Related]
34. Intra-herb pharmacokinetics interaction between quercetin and isorhamentin.
Lan K; He JL; Tian Y; Tan F; Jiang XH; Wang L; Ye LM
Acta Pharmacol Sin; 2008 Nov; 29(11):1376-82. PubMed ID: 18954533
[TBL] [Abstract][Full Text] [Related]
35. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
36. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.
Choi SJ; Shin SC; Choi JS
Arch Pharm Res; 2011 Feb; 34(2):309-15. PubMed ID: 21380815
[TBL] [Abstract][Full Text] [Related]
37. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
38. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
[TBL] [Abstract][Full Text] [Related]
40. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
